Intense regulated pulse light for the meibomian gland dysfunction.

Area of Science:

• Ophthalmology
• Medical Technology

Background:

• Meibomian gland dysfunction (MGD) is a common cause of evaporative dry eye.
• Current treatments for MGD have limitations in efficacy and patient compliance.

Purpose of the Study:

• To evaluate the therapeutic effect of intense regulated pulse light (E-Eye; E-Swin) on MGD.
• To assess the impact of E-Eye treatment on both subjective and objective measures of dry eye disease.

Main Methods:

• A prospective study involving 26 patients with MGD treated with three sessions of E-Eye.
• Evaluated subjective (Ocular Surface Disease Index, Standard Patient Evaluation of Eye Dryness) and objective (Schirmer I test, tear break-up time, Oxford grading) parameters.
• Compared outcomes at 15 and 45 days post-treatment with baseline values.

Main Results:

• Significant improvements were observed in Schirmer I test scores and tear break-up times by Day 45 (p < 0.001).
• Both Ocular Surface Disease Index and Standard Patient Evaluation of Eye Dryness scores showed significant reductions (p < 0.05).
• All patients reported symptom relief by Day 45, with no adverse ocular effects noted.

Conclusions:

• Intense regulated pulse light (E-Eye) is a safe and effective treatment for meibomian gland dysfunction.
• The therapy enhances tear film quality and alleviates dry eye symptoms.
• Further research may explore long-term efficacy and optimal treatment protocols.